It was previously shown that treatment with the GLP-1R agonist liraglutide suppresses the progression of diabetic nephropathy in mice, as demonstrated by reduced markers of renal fibrosis and decreased glomerular oxidative stress28. Here, GLP1R is linked to diabetic kidney disease.